Is Proteus syndrome hereditary?

TL;DR: Proteus syndrome is a genetic condition caused by a post-zygotic, somatic mutation in the AKT1 gene, meaning it is not hereditary and cannot be passed from parent to child. Because the mutation occurs spontaneously after conception, there is no increased risk of recurrence for future pregnancies in affected families.

Is Proteus syndrome a hereditary condition?

While Proteus syndrome is a genetic condition, it is strictly non-hereditary. In genetics, we distinguish between germline mutations—which are present in the egg or sperm and can be passed to offspring—and somatic mutations. Proteus syndrome is caused by a sporadic, post-zygotic mutation in the AKT1 gene. This means the genetic alteration occurs in a single cell after fertilization during early embryonic development. As the embryo grows, only the cells descended from that mutated cell carry the genetic change, resulting in the mosaic pattern of tissue overgrowth characteristic of Proteus syndrome.

What is the risk of passing Proteus syndrome to children?

Because the AKT1 mutation associated with Proteus syndrome is somatic and not present in the germline (the reproductive cells), it is not passed from parents to children. There are no recorded cases of Proteus syndrome being inherited. For parents who have a child with this condition, the risk of having another child with the same diagnosis is not higher than that of the general population. The occurrence is considered a "de novo" or spontaneous event.

How is Proteus syndrome diagnosed genetically?

Genetic diagnosis for Proteus syndrome can be complex due to the nature of mosaicism. Because the mutation is not present in every cell of the body, standard blood tests may not detect it. Clinical geneticists use specific diagnostic approaches to confirm the condition:

• Targeted Biopsy: Genetic testing is most accurate when performed on tissue samples taken directly from the affected, overgrown areas of the body.


• High-Depth Sequencing: Because the mutation may be present in only a small percentage of cells, laboratories must use high-depth sequencing techniques to detect the AKT1 variant.


• Clinical Evaluation: Diagnosis is often based on the NIH diagnostic criteria, which include a history of progressive overgrowth and specific skin lesions like cerebriform connective tissue nevi.

What is the role of genetic counseling for families?

Genetic counseling is highly recommended for families affected by Proteus syndrome. Even though the condition is not hereditary, a counselor provides essential support by explaining the mechanism of mosaicism and confirming that the parents are not at risk of having another affected child. Counselors at DiseaseMaps.org and other specialized centers help families navigate the emotional impact of the diagnosis and coordinate with multidisciplinary medical teams to manage the complex, progressive nature of Proteus syndrome. They can also assist in identifying specialized research centers that focus on AKT1-related disorders.

Next steps

• Consult with a clinical geneticist to confirm the diagnosis through specialized tissue sampling if necessary.


• Connect with the community of 5+ members on DiseaseMaps.org to share experiences and coping strategies.


• Review the latest clinical trial information via the NIH GARD portal to see if any targeted therapies for AKT1 pathway inhibitors are currently accessible.


• Maintain regular follow-ups with a multidisciplinary team, including orthopedic surgeons, dermatologists, and pediatricians familiar with overgrowth syndromes.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Proteus Syndrome.


• Orphanet: Proteus Syndrome (ORPHA:744).


• OMIM (Online Mendelian Inheritance in Man): Proteus Syndrome; PS (#176920).


• The Proteus Syndrome Foundation: Patient resources and research updates.